VolitionRX Limited (VNRX): Price and Financial Metrics

VNRX POWR Grades

• VNRX scores best on the Sentiment dimension, with a Sentiment rank ahead of 93.04% of US stocks.
• The strongest trend for VNRX is in Stability, which has been heading down over the past 175 days.
• VNRX ranks lowest in Value; there it ranks in the 10th percentile.

VNRX Stock Summary

• VOLITIONRX LTD's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 6.44% of US listed stocks.
• VNRX's price/sales ratio is 339.79; that's higher than the P/S ratio of 98.82% of US stocks.
• Revenue growth over the past 12 months for VOLITIONRX LTD comes in at 240.3%, a number that bests 96.8% of the US stocks we're tracking.
• Stocks that are quantitatively similar to VNRX, based on their financial statements, market capitalization, and price volatility, are GANX, GTHX, MNTS, ACER, and FKWL.
• VNRX's SEC filings can be seen here. And to visit VOLITIONRX LTD's official web site, go to www.volition.com.

VNRX Valuation Summary

• VNRX's price/earnings ratio is -3.4; this is 114.66% lower than that of the median Healthcare stock.
• Over the past 135 months, VNRX's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for VNRX.

VNRX Growth Metrics

Its 3 year net cashflow from operations growth rate is now at 21.36%.
• Its 2 year price growth rate is now at -44.15%.
• Its year over year price growth rate is now at -25.24%.

Over the past 49 months, VNRX's revenue has gone up $200,917.

The table below shows VNRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	0.200917	-14.50401	-31.06183
2022-06-30	0.193686	-12.56319	-30.4553
2022-03-31	0.178716	-11.69893	-28.33255
2021-12-31	0.090035	-20.85392	-26.81467
2021-09-30	0.082915	-19.17901	-23.91666
2021-06-30	0.058007	-18.80059	-21.10812

VNRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VNRX has a Quality Grade of D, ranking ahead of 5.68% of graded US stocks.
• VNRX's asset turnover comes in at 0.002 -- ranking 424th of 680 Pharmaceutical Products stocks.
• CDTX, KALA, and NVS are the stocks whose asset turnover ratios are most correlated with VNRX.

The table below shows VNRX's key quality metrics over time.